Combinations of Janssen farnesyltransferase inhibitor with other chemotherapeutic agents Oct. 29, 2001
Feasibility of different schedule of administration assessed for ET-743 in clinical trial Oct. 29, 2001
SU-5416 may be useful in certain patients with c-kit-positive AML, according to phase II data Oct. 26, 2001
RSS